Champions Oncology CSBR Peer Comparison

NASDAQ CSBR
$5.01 -0.09 (-1.76%)
As of: Sep 9, 2026 · 3:58 PM EDT
Peer Comparison

300 Comparable Companies

Industry Contract Research

Champions Oncology, Inc. (CSBR) is the 297th largest of 300 Contract Research companies by market capitalisation, at 69.16 Mn, behind Galectin Therapeutics Inc at 266.79 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 IQV Iqvia Holdings Inc. primary H-11 Pharma Services HG-03 42.77 Bn 32.40 2.52 40.69 Bn
2 MEDP Medpace Holdings, Inc. primary H-11 Pharma Services HG-03 16.50 Bn 33.58 5.93 16.00 Bn
3 CRL Charles River Laboratories International, Inc. primary H-11 Pharma Services HG-03 13.37 Bn -56.26 3.34 13.18 Bn
4 ICLR Icon Plc primary H-11 Pharma Services HG-03 12.49 Bn 16.05 1.51 11.56 Bn
5 FTRE Fortrea Holdings Inc. primary H-11 Pharma Services HG-03 1.58 Bn -18.59 0.59 1.42 Bn
6 EVO Evotec SE primary H-11 Pharma Services HG-03 0.64 Bn — — 0.22 Bn
7 DNA Ginkgo Bioworks Holdings, Inc. primary H-11 Pharma Services HG-03 0.42 Bn -1.45 3.78 0.34 Bn
8 CSBR Champions Oncology, Inc. primary H-11 Pharma Services HG-03 0.07 Bn -58.86 1.16 0.07 Bn
9 HYFT MindWalk Holdings Corp. primary H-11 Pharma Services HG-03 0.06 Bn -5.79 5.31 0.05 Bn
10 VIVS VivoSim Labs, INC. primary H-11 Pharma Services HG-03 0.00 Bn -0.13 12.96 0.00 Bn
11 NOTVQ Inotiv, Inc. primary H-11 Pharma Services HG-03 0.00 Bn 0.00 0.00 -0.01 Bn
12 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 643.26 Bn 30.58 6.57 622.50 Bn
13 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 443.31 Bn 70.19 6.89 436.74 Bn
14 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 364.74 Bn 115.10 5.48 357.60 Bn
15 UNH Unitedhealth Group Inc secondary H-18 Healthcare Payers and Distributors HG-05 354.24 Bn 23.76 0.79 322.77 Bn
16 TMO Thermo Fisher Scientific Inc. secondary H-10 Medical Devices and Diagnostics HG-02 225.48 Bn 32.03 4.87 221.41 Bn
17 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.73 Bn 24.22 5.56 197.74 Bn
18 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 180.92 Bn -62.49 5.94 177.74 Bn
19 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.16 Bn 30.00 10.50 124.30 Bn
20 MCK Mckesson Corp secondary H-19 Healthcare Payers and Distributors HG-05 106.22 Bn 20.04 0.26 101.06 Bn
21 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.89 Bn 19.15 5.34 74.90 Bn
22 RLXXF Relx Plc secondary T-23 Business Applications TG-03 62.58 Bn — — 62.21 Bn
23 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.41 Bn 35.80 11.75 56.23 Bn
24 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 53.99 Bn -17.13 24.23 48.85 Bn
25 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.33 Bn 11.23 0.98 44.95 Bn
26 NTRA Natera, Inc. secondary H-17 Healthcare Providers HG-04 47.44 Bn -246.72 17.52 46.34 Bn
27 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.84 Bn 61.56 2.47 39.19 Bn
28 VEEV Veeva Systems Inc secondary T-27 Vertical Software TG-05 42.44 Bn 41.82 12.27 35.19 Bn
29 ROP Roper Technologies Inc secondary T-19 Business Applications TG-03 39.20 Bn 15.65 4.73 38.83 Bn
30 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 34.48 Bn 44.51 7.18 31.18 Bn
31 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.15 Bn 37.32 3.11 29.86 Bn
32 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.05 Bn -20.25 2,751.33 30.05 Bn
33 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 29.54 Bn 14.41 1.39 27.44 Bn
34 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.99 Bn -31.97 24.60 26.83 Bn
35 LH Labcorp Holdings Inc. secondary H-17 Healthcare Providers HG-04 26.30 Bn 26.21 1.83 26.16 Bn
36 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.23 Bn 15.65 4.34 20.69 Bn
37 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.72 Bn -13.92 7.67 10.06 Bn
38 GPN Global Payments Inc secondary T-54 Fintech TG-09 23.59 Bn -24.16 2.31 18.18 Bn
39 GH Guardant Health, Inc. secondary H-17 Healthcare Providers HG-04 21.64 Bn -47.72 18.29 20.59 Bn
40 SSNC SS&C Technologies Holdings Inc secondary T-20 Business Applications TG-03 18.96 Bn 22.64 2.89 18.53 Bn
41 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.20 Bn 21.48 2.14 17.79 Bn
42 LDOS Leidos Holdings, Inc. secondary I-02 Aerospace and Defense IG-01 16.21 Bn 11.62 0.92 15.46 Bn
43 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn -49.74 12.36 15.03 Bn
44 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn 18.30 11.19 14.92 Bn
45 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.65 Bn 22.19 4.64 15.26 Bn
46 SOLV Solventum Corp secondary H-06 Medical Devices and Diagnostics HG-02 15.55 Bn 10.84 1.87 15.15 Bn
47 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.22 Bn 16.17 3.31 13.60 Bn
48 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.90 Bn -21.53 20.89 14.18 Bn
49 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.62 Bn 16.98 6.00 13.78 Bn
50 TU Telus Corp secondary C-01 Telecommunications CG-01 14.48 Bn -23.06 0.65 13.37 Bn
51 RVTY Revvity, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 13.85 Bn 58.30 4.76 12.83 Bn
52 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.63 Bn — — 12.94 Bn
53 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.58 Bn 30.43 7.56 12.35 Bn
54 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.45 Bn 170.57 3.65 11.57 Bn
55 DVA Davita Inc. secondary H-14 Healthcare Providers HG-04 11.90 Bn 10.22 0.85 11.21 Bn
56 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.85 Bn -43.53 17.69 10.24 Bn
57 TEM Tempus AI, Inc. secondary H-17 Healthcare Providers HG-04 11.04 Bn -44.44 7.71 10.23 Bn
58 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
59 ALGN Align Technology Inc secondary H-09 Medical Devices and Diagnostics HG-02 10.91 Bn 26.39 2.64 9.81 Bn
60 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.89 Bn -70.84 14.02 10.57 Bn
61 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
62 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.11 Bn 18.88 3.21 9.51 Bn
63 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.05 Bn -26.35 — 9.29 Bn
64 HSIC Henry Schein Inc secondary H-19 Healthcare Payers and Distributors HG-05 9.98 Bn 23.64 0.73 9.82 Bn
65 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.91 Bn 785.46 2.70 9.74 Bn
66 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.56 Bn 86.62 33.92 9.56 Bn
67 OSCR Oscar Health, Inc. secondary H-18 Healthcare Payers and Distributors HG-05 9.53 Bn 17.30 0.62 0.98 Bn
68 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.52 10.57 7.18 Bn
69 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.96 Bn -47.63 — 8.96 Bn
70 TXG 10x Genomics, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 8.77 Bn -116.67 14.21 8.21 Bn
71 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
72 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.47 Bn -8.54 51.11 8.12 Bn
73 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn -14.81 — 7.97 Bn
74 TWST Twist Bioscience Corp secondary H-10 Medical Devices and Diagnostics HG-02 7.86 Bn -57.50 18.21 7.70 Bn
75 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.77 Bn 17.59 9.72 7.09 Bn
76 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
77 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.38 Bn -41.27 — 7.38 Bn
78 HNGE Hinge Health, Inc. secondary H-16 Healthcare Providers HG-04 7.23 Bn 67.32 10.04 6.84 Bn
79 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.14 Bn -17.69 — 7.14 Bn
80 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.93 Bn -32.98 28.90 6.60 Bn
81 CAI Caris Life Sciences, Inc. secondary H-17 Healthcare Providers HG-04 6.82 Bn 64.87 6.89 6.03 Bn
82 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.36 Bn -28.39 1,021.85 6.36 Bn
83 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -704.68 4,533.84 6.31 Bn
84 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -7.27 10.12 5.82 Bn
85 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 75.51 7.24 5.56 Bn
86 NCSYF NICE Ltd. secondary T-26 Workplace Software TG-04 5.99 Bn 6.47 1.01 5.63 Bn
87 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn -16.20 — 5.87 Bn
88 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -15.79 — 5.84 Bn
89 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.83 Bn -33.11 1,160.93 5.65 Bn
90 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 29.31 19.90 4.42 Bn
91 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.74 Bn — — 4.01 Bn
92 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 5.57 3.39 Bn
93 RDNT RadNet, Inc. secondary H-14 Healthcare Providers HG-04 5.52 Bn 286.90 2.43 4.79 Bn
94 EXLS ExlService Holdings, Inc. secondary T-63 Technology Services TG-11 5.33 Bn 21.33 2.38 5.05 Bn
95 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.98 Bn -22.73 — 4.98 Bn
96 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.89 Bn -17.03 — 4.89 Bn
97 HAE Haemonetics Corp secondary H-06 Medical Devices and Diagnostics HG-02 4.68 Bn 48.56 3.46 4.45 Bn
98 WAY Waystar Holding Corp. secondary T-27 Vertical Software TG-05 4.57 Bn 33.94 3.79 4.38 Bn
99 DOCS Doximity, Inc. secondary T-27 Vertical Software TG-05 4.43 Bn 26.50 6.75 3.74 Bn
100 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn -7.94 1,126.80 4.06 Bn
101 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.05 Bn — — 3.64 Bn
102 HTFL Heartflow, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 4.04 Bn -166.44 19.90 3.66 Bn
103 ADPT Adaptive Biotechnologies Corp secondary H-17 Healthcare Providers HG-04 3.92 Bn -97.29 12.71 3.57 Bn
104 CCC CCC Intelligent Solutions Holdings Inc. secondary T-27 Vertical Software TG-05 3.89 Bn 91.86 3.50 3.77 Bn
105 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
106 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.83 Bn -7.15 — 3.83 Bn
107 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -13.27 366.70 3.80 Bn
108 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -18.13 11.66 3.49 Bn
109 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -29.59 — 3.60 Bn
110 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -7.79 30.64 2.88 Bn
111 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -34.90 66.37 2.56 Bn
112 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.07 15.11 2.71 Bn
113 RSMDF Resmed Inc secondary H-06 Medical Devices and Diagnostics HG-02 3.54 Bn 2.34 0.63 2.07 Bn
114 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn -20.49 50.98 3.37 Bn
115 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.18 Bn -6.15 — 3.18 Bn
116 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 109.08 6.70 2.87 Bn
117 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.02 Bn -9.83 19,122.53 3.02 Bn
118 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -28.68 — 2.99 Bn
119 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -10.96 593.06 2.44 Bn
120 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.67 — 2.95 Bn
121 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -8.57 79.61 2.48 Bn
122 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -14.90 6.24 2.10 Bn
123 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.64 Bn -81.36 — 2.64 Bn
124 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn 4.54 0.06 -3.19 Bn
125 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -8.52 49.52 2.58 Bn
126 WGS GeneDx Holdings Corp. secondary H-17 Healthcare Providers HG-04 2.57 Bn -24.21 5.67 2.44 Bn
127 PRVA Privia Health Group, Inc. secondary H-14 Healthcare Providers HG-04 2.57 Bn 76.15 1.09 2.16 Bn
128 CDNA CareDx, Inc. secondary H-17 Healthcare Providers HG-04 2.57 Bn 23.15 5.61 2.20 Bn
129 LIFE Ethos Technologies Inc. secondary H-16 Healthcare Providers HG-04 2.52 Bn -20.66 4.44 2.35 Bn
130 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.51 Bn -169.96 10.01 2.40 Bn
131 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
132 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
133 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.71 3.10 2.07 Bn
134 HURN Huron Consulting Group Inc. secondary I-26 Business Services IG-06 2.42 Bn 20.94 1.72 2.39 Bn
135 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 44.17 1.73 Bn
136 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 13.50 2.51 1.60 Bn
137 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -5.99 33.69 2.40 Bn
138 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -16.97 1.18 1.53 Bn
139 NEO Neogenomics Inc secondary H-17 Healthcare Providers HG-04 2.30 Bn -44.29 3.00 2.15 Bn
140 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2,975.41 — 2.29 Bn
141 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -5.95 4.28 1.94 Bn
142 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.28 Bn -21.11 13.44 2.28 Bn
143 CLOV Clover Health Investments, Corp. /De secondary H-18 Healthcare Payers and Distributors HG-05 2.28 Bn -124.19 0.92 2.04 Bn
144 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -36.49 12.04 2.16 Bn
145 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -3.87 — 2.00 Bn
146 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.24 — 1.86 Bn
147 FLYW Flywire Corp secondary T-54 Fintech TG-09 2.18 Bn 63.96 3.05 1.88 Bn
148 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.91 4.19 2.01 Bn
149 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.17 0.34 0.63 Bn
150 PGNY Progyny, Inc. secondary H-14 Healthcare Providers HG-04 2.12 Bn 27.02 1.62 1.89 Bn
151 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -8.78 — 2.12 Bn
152 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.11 Bn 6.70 6.76 1.66 Bn
153 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.01 20.99 2.06 Bn
154 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -15.00 102.87 2.06 Bn
155 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.04 Bn -5.16 — 2.04 Bn
156 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.03 Bn -4.89 2,033.16 2.03 Bn
157 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -13.21 53.36 1.71 Bn
158 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -9.53 71.80 1.69 Bn
159 BFLY Butterfly Network, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 1.96 Bn -26.25 17.52 1.84 Bn
160 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -11.60 18.04 1.52 Bn
161 INOD Innodata Inc secondary T-63 Technology Services TG-11 1.84 Bn 31.42 5.79 1.59 Bn
162 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -7.23 6.00 1.82 Bn
163 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.74 7.00 1.22 Bn
164 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -13.23 1,357.12 1.76 Bn
165 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -96.63 4.06 0.87 Bn
166 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
167 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 31.30 1.17 Bn
168 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.77 17.33 1.71 Bn
169 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -26.90 — 1.31 Bn
170 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.19 — 1.09 Bn
171 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.57 3.93 0.91 Bn
172 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -194.01 943.71 1.62 Bn
173 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -67.19 8.06 1.32 Bn
174 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -8.63 — 1.60 Bn
175 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.33 523.75 1.59 Bn
176 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
177 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
178 OMCL Omnicell, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 1.53 Bn 39.21 1.23 1.24 Bn
179 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -3.17 2.04 1.17 Bn
180 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -17.48 — 1.46 Bn
181 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -13.63 72.27 1.45 Bn
182 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.37 50.20 0.81 Bn
183 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.48 5.56 1.03 Bn
184 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -9.65 — 1.43 Bn
185 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.67 — 1.42 Bn
186 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -4.73 — 1.40 Bn
187 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 82.16 36.50 1.40 Bn
188 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -9.82 — 1.37 Bn
189 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.30 876.13 1.17 Bn
190 AZTA Azenta, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 1.36 Bn -4.34 1.29 1.04 Bn
191 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.64 — 1.36 Bn
192 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -6.49 — 1.33 Bn
193 TNDM Tandem Diabetes Care Inc secondary H-06 Medical Devices and Diagnostics HG-02 1.32 Bn -20.85 1.27 0.86 Bn
194 KMTS Kestra Medical Technologies, Ltd. secondary H-06 Medical Devices and Diagnostics HG-02 1.31 Bn -9.95 13.76 0.95 Bn
195 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -1.37 — 1.27 Bn
196 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 150.67 0.75 Bn
197 AFYA Afya Ltd secondary D-28 Consumer Services DG-09 1.24 Bn 5.50 1.17 1.05 Bn
198 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn -25.77 — 1.02 Bn
199 CLVT Clarivate Plc secondary T-22 Business Applications TG-03 1.22 Bn -3.67 0.51 1.01 Bn
200 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -28.00 3.10 1.11 Bn
201 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -11.87 50.76 1.22 Bn
202 EVCM EverCommerce Inc. secondary T-27 Vertical Software TG-05 1.20 Bn 35.29 2.01 1.07 Bn
203 CERT Certara, Inc. secondary T-27 Vertical Software TG-05 1.18 Bn -17.30 2.90 1.00 Bn
204 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.56 — 1.16 Bn
205 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -19.84 — 1.14 Bn
206 GDRX GoodRx Holdings, Inc. secondary T-27 Vertical Software TG-05 1.14 Bn 70.05 1.45 0.84 Bn
207 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -4.64 22.98 0.66 Bn
208 TDOC Teladoc Health, Inc. secondary H-16 Healthcare Providers HG-04 1.10 Bn -6.19 0.44 0.32 Bn
209 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.92 Bn
210 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -3.82 — 0.48 Bn
211 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -118.02 — 0.99 Bn
212 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -4.81 14.90 0.61 Bn
213 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -70.03 — 0.92 Bn
214 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -17.06 2.11 0.67 Bn
215 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -13.99 3.86 0.64 Bn
216 CBLL Ceribell, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 0.93 Bn -14.07 9.11 0.80 Bn
217 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.84 8.45 0.49 Bn
218 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 2.72 3.17 0.78 Bn
219 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -4.26 — 0.87 Bn
220 HSTM Healthstream Inc secondary T-27 Vertical Software TG-05 0.84 Bn 39.63 2.62 0.77 Bn
221 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 816.31 0.82 Bn
222 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -6.91 9.10 0.66 Bn
223 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -7.93 — 0.80 Bn
224 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.89 95.78 0.79 Bn
225 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -10.21 42.29 0.44 Bn
226 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -122.18 2.28 0.60 Bn
227 PAYS Paysign, Inc. secondary T-54 Fintech TG-09 0.73 Bn 46.50 7.29 0.56 Bn
228 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -6.21 — 0.72 Bn
229 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 12.24 5.24 0.49 Bn
230 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -6.22 — 0.61 Bn
231 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 3.03 1.72 0.59 Bn
232 CCSI Consensus Cloud Solutions, Inc. secondary T-26 Workplace Software TG-04 0.67 Bn 7.07 1.89 0.57 Bn
233 PHR Phreesia, Inc. secondary T-27 Vertical Software TG-05 0.64 Bn 61.54 1.27 0.64 Bn
234 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -16.42 1,038.05 0.57 Bn
235 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.07 1.70 0.38 Bn
236 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 502.49 8.35 0.30 Bn
237 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -8.43 — 0.62 Bn
238 CTEV Claritev Corp secondary T-27 Vertical Software TG-05 0.62 Bn -2.18 0.62 0.59 Bn
239 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.75 589.05 0.44 Bn
240 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -340,055.90 — 0.60 Bn
241 WEAV Weave Communications, Inc. secondary T-27 Vertical Software TG-05 0.58 Bn -28.25 2.26 0.53 Bn
242 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -6.72 — 0.58 Bn
243 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.79 3.43 0.43 Bn
244 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.82 — 0.57 Bn
245 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 61.21 1.80 0.00 Bn
246 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.40 — 0.57 Bn
247 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn -6.62 2.32 0.30 Bn
248 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -2.72 — 0.32 Bn
249 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.37 334.91 0.41 Bn
250 SOPH SOPHiA GENETICS SA secondary T-27 Vertical Software TG-05 0.52 Bn -6.44 6.05 0.41 Bn
251 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.67 13.43 0.46 Bn
252 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -4.48 — 0.52 Bn
253 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.41 22.27 0.22 Bn
254 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -11.04 8.89 0.20 Bn
255 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.48 Bn -5.85 330.55 0.48 Bn
256 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.22 2.47 0.40 Bn
257 EVH Evolent Health, Inc. secondary H-14 Healthcare Providers HG-04 0.47 Bn -0.92 0.22 0.33 Bn
258 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.72 — 0.45 Bn
259 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.27 78.36 0.23 Bn
260 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.55 — 0.46 Bn
261 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.39 1.99 0.37 Bn
262 NRC Nrc Health secondary T-27 Vertical Software TG-05 0.46 Bn 78.66 3.29 0.46 Bn
263 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.45 Bn 7.62 — 0.45 Bn
264 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.52 — 0.45 Bn
265 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.44 12.85 0.20 Bn
266 MTLS Materialise Nv secondary T-20 Business Applications TG-03 0.44 Bn 28.60 1.38 0.44 Bn
267 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.09 — 0.42 Bn
268 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.18 — 0.42 Bn
269 CLPT ClearPoint Neuro, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.42 Bn -14.40 9.92 0.39 Bn
270 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.40 14.27 0.23 Bn
271 HBB Hamilton Beach Brands Holding Co secondary D-06 Household Durables DG-02 0.42 Bn 7.27 0.68 0.32 Bn
272 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -5.07 — 0.41 Bn
273 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -4.36 39.58 0.41 Bn
274 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.28 — 0.24 Bn
275 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.14 39.23 0.19 Bn
276 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -6.09 5.89 0.19 Bn
277 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
278 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -1.21 134.36 0.19 Bn
279 WDH Waterdrop Inc. secondary F-16 Insurance FG-04 0.37 Bn 4.77 0.51 0.19 Bn
280 SLP Simulations Plus, Inc. secondary T-27 Vertical Software TG-05 0.37 Bn 45.81 4.54 0.32 Bn
281 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.36 Bn -8.34 0.44 0.26 Bn
282 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.02 — 0.36 Bn
283 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -4.39 78.38 0.26 Bn
284 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -4.36 — 0.35 Bn
285 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -5.03 9.00 0.26 Bn
286 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -2.03 102.81 0.32 Bn
287 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.86 — 0.32 Bn
288 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.37 — 0.32 Bn
289 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -7.50 5.28 0.14 Bn
290 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -2.69 3.39 0.14 Bn
291 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.82 64.42 0.30 Bn
292 IMRX Immuneering Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -5.02 — 0.30 Bn
293 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.08 2.13 0.28 Bn
294 BDSX Biodesix Inc secondary H-17 Healthcare Providers HG-04 0.28 Bn -9.83 2.74 0.25 Bn
295 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.70 — 0.28 Bn
296 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.46 4.56 0.28 Bn
297 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -4.74 6.17 0.23 Bn
298 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.13 12.56 0.28 Bn
299 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.04 — 0.28 Bn
300 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.52 — 0.27 Bn